University of Idaho

Moscow, Idaho, United States
Purpose
to combat enteropathogenic Escherichia coli (EPEC) diarrhea – a major cause of infant mortality – by adapting the CRISPR-Cas9 genome editing system in a dual approach to selectively destroy EPEC in the intestinal tract and to prevent reinfection.
Grantee
Division
Global Health
Date
OCTOBER 2015
Region served
GLOBAL
Committed amount
$98,975
Grant topic
Discovery and Translational Sciences
Duration (months)
30
Grantee location
Moscow, Idaho, United States
Related work

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.